bf/NASDAQ:KMDA_icon.jpeg

COM:KAMADA

Kamada Pharmaceuticals

  • Stock

USD

Last Close

5.85

22/11 21:00

Market Cap

339.10M

Beta: -

Volume Today

30.97K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
21.33M
-
23.68M
11.02%
25.88M
9.30%
25.96M
0.33%
23.33M
10.14%
25.19M
7.98%
36.24M
43.87%
42.59M
17.52%
54.72M
28.47%
68.10M
24.46%
78.27M
14.92%
average payables
13.04M
-
15.31M
17.39%
16.72M
9.22%
16.60M
0.76%
17.16M
3.37%
17.66M
2.94%
21.06M
19.24%
20.47M
2.79%
20.61M
0.67%
29.01M
40.78%
28.76M
0.87%
average receivables
17.92M
-
20.96M
17.01%
23.15M
10.44%
24.40M
5.40%
27.82M
14.02%
31.89M
14.61%
28.73M
9.90%
26.56M
7.57%
35.33M
33.05%
40.00M
13.20%
28.61M
28.47%
book value per share
2.75
-
2.25
18.13%
2.00
11.16%
1.83
8.39%
2.36
28.60%
2.77
17.62%
3.36
21.07%
4.06
21.12%
3.95
2.84%
3.95
0.07%
4.51
14.24%
capex per share
-0.17
-
-0.09
50.43%
-0.07
12.31%
-0.07
3.29%
-0.12
61.57%
-0.07
39.28%
-0.06
19.82%
-0.12
118.91%
-0.08
33.28%
-0.08
1.84%
-0.11
30.48%
capex to depreciation
-1.88
-
-1.10
41.33%
-0.84
23.66%
-0.75
10.44%
-1.26
67.41%
-0.78
38.33%
-0.51
34.65%
-1.12
120.19%
-0.67
40.66%
-0.31
53.19%
-0.46
47.84%
capex to operating cash flow
1.46
-
0.31
78.82%
0.19
37.31%
-1.39
816.02%
-1.14
17.85%
-0.27
76.09%
-0.08
69.50%
-0.29
244.34%
0.42
247.24%
-0.13
131.30%
-1.36
924.18%
capex to revenue
-0.08
-
-0.04
46.48%
-0.04
9.35%
-0.03
12.09%
-0.04
26.96%
-0.03
41.77%
-0.02
28.22%
-0.04
127.76%
-0.04
12.62%
-0.03
18.71%
-0.04
40.30%
cash per share
2.27
-
1.44
36.37%
0.78
45.87%
0.79
0.67%
1.13
44.11%
1.25
10.16%
1.83
46.87%
2.49
35.64%
0.42
83.30%
0.77
85.02%
1.03
33.84%
days of inventory on hand
181.06
-
164.80
8.98%
177.66
7.80%
167.28
5.84%
108.72
35.01%
146.59
34.83%
203.46
38.80%
178.96
12.04%
335.67
87.57%
303.82
9.49%
347.50
14.38%
days payables outstanding
116.34
-
107.15
7.89%
114.12
6.50%
106.39
6.77%
93.07
12.52%
86.43
7.13%
117.02
35.39%
68.62
41.36%
124.98
82.14%
145.39
16.33%
97.42
33.00%
days sales outstanding
111.51
-
103.28
7.38%
135.10
30.81%
107.63
20.34%
116.41
8.16%
98.79
15.14%
76.00
23.07%
72.95
4.01%
155.08
112.57%
101.49
34.56%
53.60
47.18%
debt to assets
0.12
-
0.06
46.17%
0.00
97.06%
0.02
866.44%
0.02
8.79%
0.01
43.05%
0.03
257.37%
0.02
29.10%
0.08
225.95%
0.06
16.38%
0.03
60.83%
debt to equity
0.18
-
0.09
48.68%
0.00
97.20%
0.03
926.26%
0.02
16.69%
0.01
48.70%
0.04
273.44%
0.03
34.90%
0.14
398.11%
0.12
15.02%
0.04
68.89%
dividend yield
earnings yield
0.00
-
-0.09
10,251.23%
-0.07
18.87%
-0.03
54.77%
0.04
211.62%
0.11
190.52%
0.08
26.55%
0.06
25.51%
-0.01
112.58%
-0.01
71.44%
0.03
294.32%
enterprise value
443.57M
-
129.64M
70.77%
145.42M
12.17%
190.29M
30.86%
171.56M
9.84%
185.88M
8.34%
238.48M
28.30%
219.53M
7.95%
300.36M
36.82%
165.19M
45.00%
282.06M
70.75%
enterprise value over ebitda
63.46
-
-19.94
131.42%
-18.80
5.70%
-125.94
569.80%
14.96
111.88%
7.82
47.76%
8.38
7.25%
8.72
4.08%
57.67
561.01%
15.71
72.75%
11.72
25.42%
ev to operating cash flow
-115.09
-
-13.07
88.64%
-10.40
20.41%
100.31
1,064.30%
44.10
56.03%
17.63
60.04%
8.65
50.93%
11.49
32.85%
-34.06
396.40%
5.78
116.97%
64.36
1,013.70%
ev to sales
6.28
-
1.80
71.30%
2.07
15.07%
2.46
18.40%
1.67
32.05%
1.62
2.68%
1.88
15.47%
1.65
12.13%
2.90
75.90%
1.28
55.93%
1.95
52.56%
free cash flow per share
-0.29
-
-0.36
24.43%
-0.46
27.52%
-0.02
95.57%
-0.01
27.94%
0.19
1,383.85%
0.63
231.60%
0.31
50.56%
-0.28
190.46%
0.56
298.40%
-0.03
105.22%
free cash flow yield
-0.02
-
-0.10
386.93%
-0.11
16.88%
-0.00
96.63%
-0.00
18.18%
0.04
1,332.50%
0.09
142.75%
0.05
47.89%
-0.04
189.09%
0.14
425.56%
-0.00
103.42%
graham net net
1.59
-
1.15
27.75%
0.87
24.32%
0.70
18.95%
1.20
70.49%
1.55
29.08%
1.91
23.18%
2.69
41.09%
-1.26
146.93%
-1.14
9.88%
0.09
108.24%
graham number
0.92
-
4.22
360.86%
3.74
11.32%
2.76
26.19%
3.10
12.44%
5.86
88.66%
6.46
10.21%
5.97
7.48%
2.10
64.77%
2.15
2.18%
3.96
84.06%
income quality
-8.70
-
0.78
109.02%
1.24
58.03%
-0.28
122.71%
0.56
300.07%
0.47
16.09%
1.24
161.96%
1.11
10.04%
3.95
254.80%
-12.32
411.43%
0.52
104.23%
intangibles to total assets
0.00
-
0.00
15.48%
0.00
38.51%
0.00
525.19%
0
100%
0.00
Infinity%
0.00
92.54%
0.01
313.05%
0.48
6,708.57%
0.46
5.39%
0.40
12.84%
interest coverage
1.17
-
-3.52
400.27%
-12.23
247.12%
-46.36
279.01%
45.95
199.12%
56.64
23.27%
77.76
37.28%
72.32
7.00%
-0.31
100.43%
-1.80
472.45%
8.46
570.71%
interest debt per share
0.59
-
0.29
50.29%
0.03
89.48%
0.05
68.71%
0.06
8.22%
0.04
29.38%
0.15
275.31%
0.12
20.94%
0.57
383.34%
0.48
15.73%
0.19
60.88%
inventory turnover
2.02
-
2.21
9.86%
2.05
7.24%
2.18
6.20%
3.36
53.87%
2.49
25.83%
1.79
27.95%
2.04
13.69%
1.09
46.69%
1.20
10.48%
1.05
12.57%
invested capital
0.18
-
0.09
48.68%
0.00
97.20%
0.03
926.26%
0.02
16.69%
0.01
48.70%
0.04
273.44%
0.03
34.90%
0.14
398.11%
0.12
15.02%
0.04
68.89%
market cap
486.47M
-
136.69M
71.90%
150.28M
9.94%
198.48M
32.08%
182.26M
8.17%
202.69M
11.21%
275.39M
35.87%
284.79M
3.41%
294.60M
3.44%
178.85M
39.29%
328.49M
83.67%
net current asset value
68.28M
-
59.05M
13.52%
51.11M
13.44%
44.12M
13.67%
64.27M
45.65%
85.15M
32.50%
105.08M
23.41%
145.89M
38.83%
-11.80M
108.09%
-7.35M
37.67%
58.59M
896.67%
net debt to ebitda
-6.14
-
1.08
117.68%
0.63
42.09%
5.42
762.94%
-0.93
117.21%
-0.71
24.21%
-1.30
83.52%
-2.59
99.88%
1.11
142.68%
-1.30
217.37%
-1.93
48.49%
net income per share
0.01
-
-0.35
2,694.13%
-0.31
11.49%
-0.18
40.54%
0.18
198.31%
0.55
202.62%
0.55
0.34%
0.39
29.33%
-0.05
112.77%
-0.05
4.48%
0.15
396.57%
operating cash flow per share
-0.12
-
-0.28
134.04%
-0.39
39.88%
0.05
113.51%
0.10
96.68%
0.26
153.93%
0.68
162.84%
0.43
36.43%
-0.20
145.31%
0.64
425.39%
0.08
87.26%
payables turnover
3.14
-
3.41
8.57%
3.20
6.10%
3.43
7.27%
3.92
14.32%
4.22
7.68%
3.12
26.14%
5.32
70.53%
2.92
45.10%
2.51
14.04%
3.75
49.25%
receivables turnover
3.27
-
3.53
7.97%
2.70
23.55%
3.39
25.53%
3.14
7.54%
3.69
17.83%
4.80
29.99%
5.00
4.17%
2.35
52.96%
3.60
52.81%
6.81
89.32%
research and ddevelopement to revenue
0.18
-
0.22
23.50%
0.24
5.78%
0.21
11.08%
0.12
44.45%
0.09
26.87%
0.10
20.58%
0.10
0.53%
0.11
7.29%
0.10
7.06%
0.09
8.04%
return on tangible assets
0.00
-
-0.11
3,423.03%
-0.11
4.57%
-0.07
38.71%
0.06
183.40%
0.16
185.90%
0.13
20.63%
0.08
36.11%
-0.01
116.49%
-0.01
2.04%
0.04
395.12%
revenue per share
2.16
-
2.00
7.38%
1.93
3.26%
2.13
10.00%
2.71
27.26%
2.82
4.27%
3.15
11.71%
3.03
3.88%
2.31
23.65%
2.90
25.27%
2.70
7.00%
roe
0.00
-
-0.16
3,268.48%
-0.16
0.37%
-0.10
35.10%
0.08
176.44%
0.20
157.29%
0.16
17.12%
0.10
41.65%
-0.01
113.14%
-0.01
4.56%
0.03
359.60%
roic
0.03
-
-0.12
474.28%
-0.16
25.29%
-0.11
26.10%
0.08
168.38%
0.19
137.14%
0.15
18.69%
0.09
37.53%
-0.00
102.45%
-0.01
265.95%
0.04
602.63%
sales general and administrative to revenue
0.11
-
0.11
5.17%
0.10
4.89%
0.10
1.78%
0.08
18.42%
0.07
7.44%
0.07
2.94%
0.08
5.26%
0.12
60.23%
0.10
18.81%
0.13
27.38%
shareholders equity per share
2.75
-
2.25
18.13%
2.00
11.16%
1.83
8.39%
2.36
28.60%
2.77
17.62%
3.36
21.07%
4.06
21.12%
3.95
2.84%
3.95
0.07%
4.51
14.24%
stock based compensation to revenue
0.02
-
0.05
177.55%
0.03
47.85%
0.01
49.19%
0.00
66.01%
0.01
76.31%
0.01
10.41%
0.01
19.81%
0.01
30.39%
0.01
74.65%
0.01
1.82%
tangible asset value
89.83M
-
80.89M
9.95%
72.45M
10.43%
66.41M
8.34%
89.49M
34.75%
112.25M
25.43%
135.02M
20.28%
177.15M
31.20%
23.16M
86.93%
28.95M
24.99%
102.05M
252.51%
tangible book value per share
2.75
-
2.25
18.13%
2.00
11.16%
1.83
8.39%
2.36
28.60%
2.77
17.49%
3.35
20.93%
4.03
20.37%
0.52
87.17%
0.65
25.74%
1.91
192.99%
working capital
85.11M
-
66.78M
21.53%
57.66M
13.67%
49.87M
13.50%
67.49M
35.32%
87.32M
29.39%
110.82M
26.91%
152.95M
38.01%
75.99M
50.32%
63.30M
16.70%
119.37M
88.58%

All numbers in USD (except ratios and percentages)